they've already stated that launches will start in Q2, that product is being shipped to certain partners in Q2, no announcement today which is very disappointing,but that doesn't mean it won't happen in Q2, an Actavis deal in Q2 would be great too
Binchey, I know you follow and are well informed about a number of Biotech stocks. Since it appears that Biotechs have been crushed and are going to continue to take a beating over the short term. Where does APRI fit compared to the other Biotechs you follow since Jan 1? Is this just the tide going out for Biotechs or is this drop in PPS an APRI issue? RVL